Effects of ferumoxytol on quantitative PET measurements in simultaneous PET/MR whole-body imaging: a pilot study in a baboon model

Published on Feb 26, 2015in EJNMMI Physics2.574
· DOI :10.1186/S40658-015-0109-0
Ronald Borra35
Estimated H-index: 35
(Harvard University),
Hoonsung Cho17
Estimated H-index: 17
(Chonnam National University)
+ 7 AuthorsJacob M. Hooker51
Estimated H-index: 51
(Harvard University)
Sources
Abstract
Background: Simultaneous PET/MR imaging depends on MR-derived attenuation maps (mu-maps) for accurate attenuation correction of PET data. Currently, these maps are derived from gradient-echo-based MR sequences, which are sensitive to susceptibility changes. Iron oxide magnetic nanoparticles have been used in the measurement of blood volume, tumor microvasculature, tumor-associated macrophages, and characterizing lymph nodes. Our aim in this study was to assess whether the susceptibility effects associated with iron oxide nanoparticles can potentially affect measured 18 F-FDG PET standardized uptake values (SUV) through effects on MR-derived attenuation maps. Methods: The study protocol was approved by the Institutional Animal Care and Use Committee. Using a Siemens Biograph mMR PET/MR scanner, we evaluated the effects of increasing concentrations of ferumoxytol and ferumoxytol aggregates on MR-derived mu-maps using an agarose phantom. In addition, we performed a baboon experiment evaluating the effects of a single i.v. ferumoxytol dose (10 mg/kg) on the liver, spleen, and pancreas 18 F-FDG SUV at baseline (ferumoxytol-naive), within the first hour and at 1, 3, 5, and 11 weeks. Results: Phantom experiments showed mu-map artifacts starting at ferumoxytol aggregate concentrations of 10 to 20 mg/kg. The in vivo baboon data demonstrated a 53% decrease of observed 18 F-FDG SUV compared to baseline within the first hour in the liver, persisting at least 11 weeks. Conclusions: A single ferumoxytol dose can affect measured SUV for at least 3 months, which should be taken into account when administrating ferumoxytol in patients needing sequential PET/MR scans. Advances in knowledge 1. Ferumoxytol aggregates, but not ferumoxytol alone, produce significant artifacts in MR-derived attenuation correction maps at approximate clinical dose levels of 10 mg/kg. 2. When performing simultaneous whole-body 18 F-FDG PET/MR, a single dose of ferumoxytol can result in observed SUV decreases up to 53%, depending on the amount of ferumoxytol aggregates in the studied tissue. Implications for patient care Administration of a single, clinically relevant, dose of ferumoxytol can potentially result in changes in observed SUV for a prolonged period of time in the setting of (Continued on next page)
📖 Papers frequently viewed together
9 Citations
10 Citations
37 Citations
References27
Newest
#1Brian T. Farrell (OHSU: Oregon Health & Science University)H-Index: 1
#2Bronwyn E. Hamilton (OHSU: Oregon Health & Science University)H-Index: 23
Last. Edward A. Neuwelt (OHSU: Oregon Health & Science University)H-Index: 85
view all 11 authors...
Objective: The study goal was to assess the benefits and potential limitations in the use of ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles in the MRI diagnosis of CNS inflammatory diseases and primary CNS lymphoma. Methods: Twenty patients with presumptive or known CNS lesions underwent MRI study. Eighteen patients received both gadolinium-based contrast agents (GBCAs) and 1 of 2 USPIO contrast agents (ferumoxytol and ferumoxtran-10) 24 hours apart, which allowed direct comparati...
51 CitationsSource
#1Andrew J. Gunn (Partners HealthCare)H-Index: 12
Last. Mukesh G. HarisinghaniH-Index: 55
view all 6 authors...
OBJECTIVE. Ultrasmall superparamagnetic iron oxide nanoparticles, such as ferumoxytol, produce decreased MR signal on susceptibility-inducing T2*-weighted sequences in tissues of the reticuloendothelial system. However, acute iron deposition in the adrenals has not been reported. The purpose of this article is to report our initial observations of the imaging behavior of the normal adrenals on ferumoxytol-enhanced T2*-weighted magnetic resonance imaging. SUBJECTS AND METHODS. Quantitative T2* im...
13 CitationsSource
#1Nicola Schieda (U of O: University of Ottawa)H-Index: 28
Background: Ferumoxytol is a safe and effective parenteral therapy used for the treatment of iron deficiency anaemia that has recently been approved for use in North America and in Europe.
17 CitationsSource
#1Neil D. Goldberg (UMD: University of Maryland, College Park)H-Index: 3
Iron deficiency anemia is the most common form of anemia worldwide, caused by poor iron intake, chronic blood loss, or impaired absorption. Patients with inflammatory bowel disease (IBD) are increasingly likely to have iron deficiency anemia, with an estimated prevalence of 36%–76%. Detection of iron deficiency is problematic as outward signs and symptoms are not always present. Iron deficiency can have a significant impact on a patient’s quality of life, necessitating prompt management and trea...
43 CitationsSource
#1Brendan J. McCullough (UW: University of Washington)H-Index: 8
#2Orpheus Kolokythas (UW: University of Washington)H-Index: 19
Last. Douglas Green (UW: University of Washington)H-Index: 15
view all 4 authors...
Ferumoxytol is an iron-containing parenteral treatment for iron deficiency anemia that was recently approved by the Food and Drug Administration. The iron is in the form of a superparamagnetic iron oxide that causes T1, T2, and T2* shortening on magnetic resonance imaging (MRI). Furthermore, the drug has a long intravascular half-life of 14–15 hours; a standard dose can affect MRI for days to months. We describe a case in which a patient underwent contrast-enhanced MRI of the liver 2 days after ...
49 CitationsSource
#1Ciprian Catana (Harvard University)H-Index: 40
#2Alexander R. Guimaraes (Harvard University)H-Index: 32
Last. Bruce R. Rosen (Harvard University)H-Index: 167
view all 3 authors...
Positron emission tomography (PET) and magnetic resonance imaging (MRI) are imaging modalities routinely used for clinical and research applications. Integrated scanners capable of acquiring PET and MRI data in the same imaging session, sequentially or simultaneously, have recently become available for human use. In this manuscript, we describe some of the technical advances that allowed the development of human PET/MR scanners, briefly discuss methodological challenges and opportunities provide...
91 CitationsSource
#1Csanad Varallyay (OHSU: Oregon Health & Science University)H-Index: 21
#2Eric G. Nesbit (OHSU: Oregon Health & Science University)H-Index: 4
Last. Edward A. Neuwelt (OHSU: Oregon Health & Science University)H-Index: 85
view all 10 authors...
Cerebral blood volume (CBV) measurement complements conventional magnetic resonance imaging (MRI) to indicate pathologies in the central nervous system (CNS). Dynamic susceptibility contrast (DSC) perfusion imaging is limited by low resolution and distortion. Steady-state (SS) imaging may provide higher resolution CBV maps but was not previously possible in patients. We tested the feasibility of clinical SS-CBV measurement using ferumoxytol, a nanoparticle blood pool contrast agent. SS-CBV measu...
75 CitationsSource
#1Seymur Gahramanov (OHSU: Oregon Health & Science University)H-Index: 18
#2Leslie L. Muldoon (OHSU: Oregon Health & Science University)H-Index: 53
Last. Edward A. NeuweltH-Index: 85
view all 9 authors...
Tumor blood volume assessment by using perfusion MR imaging with ferumoxytol may help differentiate true tumor progression from pseudoprogression in patients with glioblastoma multiforme who show disease progression at conventional MR imaging after chemotherapy and radiation therapy.
120 CitationsSource
#1Gudrun Wagenknecht (Forschungszentrum Jülich)H-Index: 11
#2H.-J. Kaiser (RWTH Aachen University)H-Index: 15
Last. Hans Herzog (Forschungszentrum Jülich)H-Index: 65
view all 4 authors...
In current combined PET/MR systems, PET attenuation correction is based on MRI, since the small bore inside MRI systems and the strong magnetic field do not permit a rotating PET transmission source or a CT device to be integrated. Unlike CT measurements in PET/CT scanners, the MR signal is not directly correlated to tissue density and thus cannot be converted by a simple transformation of intensity values. Various approaches have been developed based on templates, atlas information, direct segm...
174 CitationsSource
ObjectiveThe purpose of this study was to monitor iron clearance from the liver by means of T2 and T2* mapping after administration of an ultrasmall superparamagnetic iron oxide (USPIO) agent.Materials and MethodsThe study was performed using ferumoxytol (Feraheme), a USPIO agent that has been appro
50 CitationsSource
Cited By7
Newest
Attenuation correction has been one of the main methodological challenges in the integrated positron emission tomography and magnetic resonance imaging (PET/MRI) field. As standard transmission or computed tomography approaches are not available in integrated PET/MRI scanners, MR-based attenuation correction approaches had to be developed. Aspects that have to be considered for implementing accurate methods include the need to account for attenuation in bone tissue, normal and pathological lung ...
3 CitationsSource
#1Anne M. Muehe (Stanford University)H-Index: 5
#2Ketan Yerneni (Stanford University)H-Index: 5
Last. Heike E. Daldrup-Link (Stanford University)H-Index: 52
view all 10 authors...
Purpose Tumor response assessments on positron emission tomography (PET)/magnetic resonance imaging (MRI) scans require correct quantification of radiotracer uptake in tumors and normal organs. Historically, MRI scans have been enhanced with gadolinium (Gd)-based contrast agents, which are now controversial due to brain deposition. Recently, ferumoxytol nanoparticles have been identified as an alternative to Gd-based contrast agents because they provide strong tissue enhancement on MR images but...
3 CitationsSource
#1Yaser Hadi Gholami (USYD: University of Sydney)H-Index: 6
#2Hushan Yuan (Harvard University)H-Index: 18
Last. Zdenka Kuncic (USYD: University of Sydney)H-Index: 27
view all 8 authors...
Purpose: This study aimed to develop a chelate-free radiolabeled nanoparticle platform for simultaneous positron emission tomography (PET) and magnetic resonance (MR) imaging that provides contrast-enhanced diagnostic imaging and significant image quality gain by integrating the high spatial resolution of MR with the high sensitivity of PET. Methods: A commercially available super-paramagnetic iron oxide nanoparticle (SPION) (Feraheme((R)), FH) was labeled with the [(89)Zr]Zr using a novel chela...
3 CitationsSource
#1Joseph Lillington (UCL: University College London)H-Index: 1
#2Ludovica Brusaferri (UCL: University College London)H-Index: 3
Last. David Atkinson (UCL: University College London)H-Index: 68
view all 12 authors...
Positron emission tomography/magnetic resonance imaging (PET/MRI) potentially offers several advantages over positron emission tomography/computed tomography (PET/CT), for example, no CT radiation dose and soft tissue images from MR acquired at the same time as the PET. However, obtaining accurate linear attenuation correction (LAC) factors for the lung remains difficult in PET/MRI. LACs depend on electron density and in the lung, these vary significantly both within an individual and from perso...
12 CitationsSource
#1Anne M. Muehe (Lucile Packard Children's Hospital)H-Index: 5
#2Ashok J. Theruvath (Stanford University)H-Index: 7
Last. Heike E. Daldrup-Link (Stanford University)H-Index: 52
view all 12 authors...
Purpose To provide clinically useful gadolinium-free whole-body cancer staging of children and young adults with integrated positron emission tomography/magnetic resonance (PET/MR) imaging in less than 1 h.
17 CitationsSource
#1Florian Büther (WWU: University of Münster)H-Index: 14
#2Benjamin NotoH-Index: 5
Last. Lars SteggerH-Index: 30
view all 5 authors...
Attenuation correction is one of the most important steps in producing quantitative PET image data. In hybrid PET-MRI systems, this correction is far from trivial, as MRI data are not correlated to PET attenuation properties of the scanned object. Commercially available systems often employ correction schemes based on segmenting the body into different tissue classes (air, lung tissue, fat-, and water-like soft tissue), e.g. by using a dual time-point Dixon sequence. However, several pitfalls ar...
2 CitationsSource
#1Daiqin Chen (UM: University of Michigan)H-Index: 17
#2Casey A. Dougherty (UM: University of Michigan)H-Index: 13
Last. Hao Hong (UM: University of Michigan)H-Index: 56
view all 5 authors...
Nuclear imaging techniques, including primarily positron emission tomography (PET) and single-photon emission computed tomography (SPECT), can provide quantitative information for a biological event in vivo with ultra-high sensitivity, however, the comparatively low spatial resolution is their major limitation in clinical application. By convergence of nuclear imaging with other imaging modalities like computed tomography (CT), magnetic resonance imaging (MRI) and optical imaging, the hybrid ima...
14 CitationsSource